The authors respond to a letter regarding a theory connecting uterine innervation, adenomyosis, and dysmenorrhea. While they were unable to differentiate the effects of adenomyosis and endometriosis in their own study due to limitations, they believe adenomyosis primarily affects uterine innervation through disruption of myometrial tissue. Involvement of the sacrouterine ligament may further disrupt innervation and is associated with more severe dysmenorrhea in endometriosis. They are conducting further analysis of pregnancy outcomes between adenomyosis with and without endometriosis. The letter discusses the challenges in separating the effects of adenomyosis and endometriosis and the potential role of the sacrouterine
The authors respond to a letter regarding a theory connecting uterine innervation, adenomyosis, and dysmenorrhea. While they were unable to differentiate the effects of adenomyosis and endometriosis in their own study due to limitations, they believe adenomyosis primarily affects uterine innervation through disruption of myometrial tissue. Involvement of the sacrouterine ligament may further disrupt innervation and is associated with more severe dysmenorrhea in endometriosis. They are conducting further analysis of pregnancy outcomes between adenomyosis with and without endometriosis. The letter discusses the challenges in separating the effects of adenomyosis and endometriosis and the potential role of the sacrouterine
The authors respond to a letter regarding a theory connecting uterine innervation, adenomyosis, and dysmenorrhea. While they were unable to differentiate the effects of adenomyosis and endometriosis in their own study due to limitations, they believe adenomyosis primarily affects uterine innervation through disruption of myometrial tissue. Involvement of the sacrouterine ligament may further disrupt innervation and is associated with more severe dysmenorrhea in endometriosis. They are conducting further analysis of pregnancy outcomes between adenomyosis with and without endometriosis. The letter discusses the challenges in separating the effects of adenomyosis and endometriosis and the potential role of the sacrouterine